Alice Tran
Family Medicine · Richardson, TXNPI 1134792898
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 171 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 31 manufacturers, the largest accounting for just 13.0% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2022 at $1,265 and has fallen 96.1% since, to $50 in 2025.
Across 171 payments — averaging $18.07 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$403
- AstraZeneca$400
- Novo Nordisk$332
- Lilly USA, LLC$308
- Bayer$223
- GSK$209
- plus $1K from 25 others
What the payments were for
- Food & beverage$3,090100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 24 | $403 |
| AstraZeneca | 20 | $400 |
| Novo Nordisk | 24 | $332 |
| Lilly USA, LLC | 20 | $308 |
| Bayer | 12 | $223 |
| GSK | 7 | $209 |
| Biohaven Pharmaceuticals, Inc. | 3 | $126 |
| Amgen | 6 | $124 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 7 | $107 |
| Boehringer Ingelheim | 5 | $100 |
| Ironwood Pharmaceuticals, Inc | 4 | $80 |
| Amarin Pharma, Inc. | 4 | $72 |
| Bausch Health US, LLC | 4 | $71 |
| Johnson & Johnson | 3 | $67 |
| Eisai Inc. | 4 | $61 |
| Kowa Pharmaceuticals America, Inc. | 4 | $59 |
| Sunovion Pharmaceuticals Inc. | 3 | $55 |
| Pfizer | 2 | $45 |
| Sanofi-aventis U.S. LLC | 2 | $30 |
| Currax Pharmaceuticals LLC | 2 | $28 |
| Teva Pharmaceuticals USA, Inc. | 1 | $21 |
| Esperion Therapeutics, Inc. | 1 | $21 |
| Astellas Pharma US Inc | 1 | $20 |
| Gilead | 1 | $20 |
| Linus Health, Inc. | 1 | $19 |
| Dexcom, Inc. | 1 | $18 |
| Genentech USA, Inc. | 1 | $17 |
| Biohaven Pharmaceutical Holding Company Ltd. | 1 | $14 |
| Arbor Pharmaceuticals, Inc. | 1 | $14 |
| Idorsia Pharmaceuticals US Inc | 1 | $13 |
| Medicure Pharma Inc. | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- SHINGRIX$115
- NURTEC ODT$106
- BREZTRI$102
How this compares
$3,090 in reported general payments places this provider in the 80th percentile of 8,760 family medicine providers in Texas.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Metformin Hcl | 21 | $104 |
| Amlodipine Besylate | 12 | $71 |
Paid to pharmacies, not to this prescriber.
Other family medicine in Richardson
- Carlos CamposNew Braunfels$1.5M
- Aaron KingSan Antonio$1.1M
- Bradley WassonArlington$734K
- Cynthia BrinsonAustin$402K
- Michael MendezLubbock$368K
- Sang Tae KimAmarillo$368K
- Sumit PerakathuHarlingen$342K
- Joel SolisMcAllen$324K
- Robert CampbellFort Worth$318K
- Jose LedezmaEdinburg$300K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.